JNJ-64619178
pseudo-irreversible methyltransferase inh. oral, phase I, cancer from adenosine derivative library + opt. Molecular Cancer Therapeutics Janssen R&D
Molecules of the Month - September 2021
Molecules of the Month
- ETX0462
- milvexian
- GSK3685032
- JNJ-64619178
- vimseltinib
- ARD-2585
- AZD5305
- SAR247799
- IM156
- BMS-986158
- JNJ-67569762
- FRM-024
- LYC-55716
- S-600918